Lab News
Blood biomarkers signal concussion in college athletes
February 7, 2020 -- Changes to biomarkers in blood tests matched concussion injuries in a recent study of college athletes. The results suggest potential for blood testing to complement clinical evaluation in determining which athletes can return to play.
Discuss
February 7, 2020 -- Changes to biomarkers in blood tests matched concussion injuries in a recent study of college athletes. The results suggest potential for blood testing to complement clinical evaluation in determining which athletes can return to play.
Discuss CMS offers guidance on use of CDC coronavirus test
February 6, 2020 -- The U.S. Centers for Medicare and Medicaid Services (CMS) on February 6 offered guidance to medical labs in the field on how to use a diagnostic test for the novel coronavirus (2019-nCoV). The guidance follows the decision by the U.S. Food and Drug Administration to grant an emergency use authorization to labs to use a test developed by the U.S. Centers for Disease Control and Prevention (CDC).
Discuss
February 6, 2020 -- The U.S. Centers for Medicare and Medicaid Services (CMS) on February 6 offered guidance to medical labs in the field on how to use a diagnostic test for the novel coronavirus (2019-nCoV). The guidance follows the decision by the U.S. Food and Drug Administration to grant an emergency use authorization to labs to use a test developed by the U.S. Centers for Disease Control and Prevention (CDC).
Discuss Abnormal urine drug tests common in cancer patients
February 6, 2020 -- Best practices for urine testing to detect nonmedical opioid use in cancer patients need some rethinking, in light of the intake of other drugs and the risk for diversion of prescribed medicines, according to a single-center study of electronic medical records published online February 6 in JAMA Oncology.
Discuss
February 6, 2020 -- Best practices for urine testing to detect nonmedical opioid use in cancer patients need some rethinking, in light of the intake of other drugs and the risk for diversion of prescribed medicines, according to a single-center study of electronic medical records published online February 6 in JAMA Oncology.
Discuss Is the new Medicare NGS payment policy really a win for patients?
February 5, 2020 -- The new Medicare policy on coverage for next-generation sequencing (NGS) was portrayed as a win for patients with hereditary breast or ovarian cancer. Patient advocate Lisa Schlager questions what it really means in terms of access.
Discuss
February 5, 2020 -- The new Medicare policy on coverage for next-generation sequencing (NGS) was portrayed as a win for patients with hereditary breast or ovarian cancer. Patient advocate Lisa Schlager questions what it really means in terms of access.
Discuss FDA shares CDC test with labs on emergency use basis
February 4, 2020 -- In a breakthrough for diagnostics amid the Wuhan coronavirus crisis, the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization paving the way for use at qualified labs of a diagnostic test developed by the U.S. Centers for Disease Control and Prevention (CDC).
Discuss
February 4, 2020 -- In a breakthrough for diagnostics amid the Wuhan coronavirus crisis, the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization paving the way for use at qualified labs of a diagnostic test developed by the U.S. Centers for Disease Control and Prevention (CDC).
Discuss Wuhan coronavirus RT-PCR tests deliver results fast
February 4, 2020 -- Scientists in Hong Kong and China have developed rapid reverse transcription polymerase chain reaction (RT-PCR) tests that may be used to identify and confirm the 2019 novel coronavirus (2019-nCoV), with fast results. Their experience with the tests was published in the journal Clinical Chemistry on January 31.
Discuss
February 4, 2020 -- Scientists in Hong Kong and China have developed rapid reverse transcription polymerase chain reaction (RT-PCR) tests that may be used to identify and confirm the 2019 novel coronavirus (2019-nCoV), with fast results. Their experience with the tests was published in the journal Clinical Chemistry on January 31.
Discuss Mass spectrometry brings speed, accuracy, specificity to labs
February 3, 2020 -- For years, mass spectrometry found extensive use as a valuable analytical tool in industries ranging from chemical processing to drug discovery and development. Now the technology has transitioned into the clinical lab, with the commercialization of mass spectrometry platforms for microbial identification.
Discuss
February 3, 2020 -- For years, mass spectrometry found extensive use as a valuable analytical tool in industries ranging from chemical processing to drug discovery and development. Now the technology has transitioned into the clinical lab, with the commercialization of mass spectrometry platforms for microbial identification.
Discuss Wuhan coronavirus spread may be vastly underestimated
January 31, 2020 -- Up to 75,815 people in the city of Wuhan, China, are estimated to be infected with the 2019 novel coronavirus (2019-nCoV), which is vastly more than official reports, according to a mathematical modeling study by Hong Kong experts that was published online January 31 in the Lancet journal.
Discuss
January 31, 2020 -- Up to 75,815 people in the city of Wuhan, China, are estimated to be infected with the 2019 novel coronavirus (2019-nCoV), which is vastly more than official reports, according to a mathematical modeling study by Hong Kong experts that was published online January 31 in the Lancet journal.
Discuss Enrichment NGS emerges as surveillance tool for coronavirus
January 31, 2020 -- As the coronavirus continues to grow as a global health concern, researchers are urgently seeking efficient methods to predict and mitigate emerging coronavirus strains. An international team believes that targeted next-generation sequencing (NGS) may be a valuable tool for monitoring both current and future outbreaks.
Discuss
January 31, 2020 -- As the coronavirus continues to grow as a global health concern, researchers are urgently seeking efficient methods to predict and mitigate emerging coronavirus strains. An international team believes that targeted next-generation sequencing (NGS) may be a valuable tool for monitoring both current and future outbreaks.
Discuss Roche, Genomica join crew of vendors with tests for coronavirus
January 30, 2020 -- Roche and PharmaMar subsidiary Genomica are among the companies that are introducing tests for the novel 2019-nCoV coronavirus, fulfilling an urgent global need for swift diagnosis.
Discuss
January 30, 2020 -- Roche and PharmaMar subsidiary Genomica are among the companies that are introducing tests for the novel 2019-nCoV coronavirus, fulfilling an urgent global need for swift diagnosis.
Discuss
News in Brief
Case Study™
Conferences
5th International Conference on Clinical Hematology and Transfusion Medicine
February 24-25
Rome, Lazio Italy
February 24-25
Rome, Lazio Italy
Clinical Laboratory Educators Conference
February 27-29
Lake Buena Vista, Florida United States
February 27-29
Lake Buena Vista, Florida United States
United States & Canadian Academy of Pathology (USCAP) Annual Meeting
February 29 - March 5
Los Angeles, California United States
February 29 - March 5
Los Angeles, California United States
Molecular Med Tri-Con
March 1-4
San Francisco, California United States
March 1-4
San Francisco, California United States
Immuno-Oncology Summit Europe 2020
March 9-12
London, Greater London United Kingdom
March 9-12
London, Greater London United Kingdom
Connect
Latest Tweets